How big is the Japan Pharmaceutical Market?

The Japan Pharmaceutical Market size is expected to reach USD 88.00 billion in 2024 and grow at a CAGR of 0.88% to reach USD 91.94 billion by 2029. Read More

What is the current Japan Pharmaceutical Market size?

In 2024, the Japan Pharmaceutical Market size is expected to reach USD 88.00 billion. Read More

What years does this Japan Pharmaceutical Market cover, and what was the market size in 2023?

In 2023, the Japan Pharmaceutical Market size was estimated at USD 87.23 billion. The report covers the Japan Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Pharmaceutical Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the opportunities for foreign companies entering the Japanese Pharmaceutical Market?

The opportunities for foreign companies entering the Japanese Pharmaceutical Market are a) Unmet medical needs b) Partnerships with Japanese firms c) Targeting specific therapeutic areas Read More

Japan Pharmaceutical Industry Analysis | Market Growth, Size & Forecast Report

Japan Pharmaceutical Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)

The report covers Japan Pharmaceutical Industry Overview and the market is segmented by Therapeutic Category (Antiallergics, Blood, and Blood Forming Organs, Cardiovascular System, Dermatologicals, Genito Urinary System, Respiratory System, Sensory Organs, and Other Therapeutic Categories), Prescription Type (Prescription Drugs (Branded Drugs and Generic Drugs) and OTC). The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Japan Pharmaceutical Industry Overview

The competitive landscape of the Japanese pharmaceutical market covers the business overview, financials, products, and strategies followed by major companies. The pharmaceutical market in Japan is highly competitive and consists of several major players. In terms of market share, a few major players are dominating the market studied. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some key companies currently dominating the market are Takeda Pharmaceutical Company Limited, Pfizer Inc., Chugai Pharmaceutical Co. Ltd, Merck & Co. Inc., and Daiichi Sankyo Company, Limited, among others.